USPTO serial 79061152
ACRUX
Reviewed by CopyMark Law Group
Reg. 3752416Status 404
- Filing date
- Status date
- Registration date
- Feb 23, 2010
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACRUX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and medicated compositions for topical and transdermal applications, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses, and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception; topical and transdermal medicated skin preparations and pharmaceutical compositions for spray application to the skin, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception; pharmaceutical preparations for transdermal delivery, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 15, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Mar 15, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 30, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 1, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 1, 2017 | INPC | INVALIDATION PROCESSED | — |
| May 30, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 30, 2016 | C71T | CANCELLED SECTION 71 | — |
| Feb 6, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 14, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 14, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 23, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 23, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 13, 2010 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 8, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 30, 2009 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 18, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 3, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 2, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 30, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 30, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2009 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 26, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2009 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 26, 2009 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 23, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 11, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 11, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 11, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 10, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 1, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 28, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 27, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |